Comprehensive Laboratory Research Overview
Eriacta 100mg is a sildenafil citrate formulation manufactured by Ranbaxy for in-vitro research applications examining phosphodiesterase type 5 (PDE5) enzyme inhibition pathways. Researchers at Stroid UK Shop utilise this compound to investigate cyclic guanosine monophosphate (cGMP) regulation in cellular models and vascular smooth muscle research protocols. The standardised 100mg dosage provides consistent experimental parameters for comparative studies examining nitric oxide signalling cascades and endothelial function investigations.
Advanced Research Applications
Laboratory scientists employ Eriacta tablets to study PDE5 enzyme kinetics, examining how selective inhibition affects intracellular cGMP concentrations in various tissue samples. Research protocols investigate the compound’s molecular interactions with catalytic domains, providing insights into phosphodiesterase enzyme family functions. Studies examine dose-response relationships in cell culture models, evaluating how different concentrations influence cyclic nucleotide metabolism. Cardiovascular research laboratories utilise this compound to investigate endothelial nitric oxide synthase pathways, examining cellular mechanisms underlying vascular smooth muscle relaxation. Advanced research explores the compound’s selectivity profile across phosphodiesterase enzyme subtypes, comparing PDE5 inhibition versus effects on related enzymes like PDE6 and PDE11. Pharmaceutical research facilities examine formulation stability, bioavailability characteristics, and pharmacokinetic properties in laboratory models. Teams investigating sildenafil research compounds often compare Ranbaxy’s formulation against reference standards to evaluate manufacturing consistency and active ingredient purity.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength | 100mg per tablet |
| Manufacturer | Ranbaxy Laboratories |
| Molecular Formula | C₂₂H₃₀N₆O₄S·C₆H₈O₇ |
| Molecular Weight | 666.7 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | PDE5 enzyme inhibition studies |
Laboratories studying selective phosphodiesterase inhibition often cross-reference findings with research conducted on selective androgen receptor modulators and research peptides to understand broader cellular signalling interactions.
Research Compliance Statement
Eriacta 100mg tablets are supplied exclusively for legitimate laboratory research purposes investigating phosphodiesterase enzyme mechanisms and cellular signalling pathways. This compound is not intended for human consumption, therapeutic applications, or any clinical use. Research institutions must maintain appropriate safety protocols and disposal procedures when handling this material. All studies should be conducted by qualified personnel in properly equipped laboratory facilities following institutional research guidelines and local regulations governing research chemical handling.
